MEETINGS & COURSES
Find a meeting
 FEATURED MEETINGS
  Rome 2010
  Kiawah Eye 2010
  OSN New York 2010
  Hawaiian Eye 2011
  Retina 2011
 
Breaking Influenza
A (H1N1) Updates
GLAUCOMA
Posted on the OSN SuperSite June 19, 2008
Inotek begins enrollment for phase 1 trial of IOP-lowering drug
Submit a Comment Submit a Comment Print  Print Email this page to a friend  E-mail

BEVERLY, Mass. — Inotek Pharmaceuticals has begun enrolling patients in a phase 1 clinical trial evaluating the safety, tolerability and IOP-lowering potential of INO-8875, a selective adenosine-1 agonist for treating glaucoma, the company announced in a press release.

Inotek received U.S. Food and Drug Administration approval to advance the drug into clinical trials in March, the release said.

"New mechanisms for lowering IOP are needed to provide physicians with alternatives for the treatment of this chronic and progressive ocular disease — especially given the expanding population of glaucoma patients," Rudolf Baumgartner, MD, Inotek's chief medical officer, said. "Highly selective adenosine-1 receptor agonists, such as ours, may provide a meaningful new approach for the management of glaucoma."

Story continues below↓

ADVERTISEMENT

The company also has other drugs in preclinical development for treating ophthalmic disorders, including diabetic retinopathy, age-related macular degeneration and uveitis, according to the release.

The OSN SuperSite is intended for physician use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will the OSN SuperSite be used for medical advice to patients.

There are no comments for this article. Be the first to comment.

Your comment

Name:
Comments:
SEE ALSO
MULTIMEDIA
The American perspective: Topographically guided LASIK (CATz)
The American perspective: Topographically guided LASIK (CATz)

Submitted by: George O. Waring III, MD, FACS, FRCOphth (7/22/2009).

more

EXCLUSIVES
GRAND ROUNDS AT THE NEW ENGLAND EYE CENTER
 Woman presents with eye pain, periorbital swelling and vision loss
A 32-year-old woman presented to the New England Eye Center at Tufts Medical Center with a 2-week history of left eye pain accompanied by periorbital swelling and progressive central vision loss.
more